R. Malik et al., COMBINATION CHEMOTHERAPY OF CANINE AND FELINE CRYPTOCOCCOSIS USING SUBCUTANEOUSLY ADMINISTERED AMPHOTERICIN-B, Australian Veterinary Journal, 73(4), 1996, pp. 124-128
Six cases (3 cats, 3 dogs) of cryptococcosis were cured using combinat
ion chemotherapy that included amphotericin B. We developed a simple,
practical and inexpensive method of administering amphotericin B as a
subcutaneous infusion during the treatment of these patients. For this
, the calculated dose of amphotericin B (0.5 to 0.8 mg/kg) was added t
o 400 mt, for cats, or to 500 mt, for dogs, of 0.45% saline containing
2.5% dextrose. These amounts were given subcutaneously 2 or 3 times w
eekly over several months, to a total cumulative dose of 8 to 26 mg/kg
body weight. Subcutaneous infusions were generally well tolerated by
the animals, although concentrations of amphotericin B in excess of 20
mg/L resulted in local irritation. This protocol enabled the administ
ration of larger, and thus more effective, quantities of amphotericin
B without producing marked azotaemia.